Will Boeing’s Outgoing CEO Dave Calhoun Retain His Board Status? Shareholders To Vote Today
Calhoun announced his retirement as part of a management shakeup following a mid-air blowout on a new 737 MAX 9 in January.
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Significant tax benefits are anticipated for the cannabis industry, following President Joe Biden's confirmation of the administration's intent to reschedule cannabis from Schedule I to Schedule III.
The $2,000 Bike That Can’t Move: Is The Peloton Fad Officially Over?
Peloton's share price closed Thursday at $3.89, down 4.42%. Its market cap is $1.44 billion (it was $49.3 billion in January 2021).
Myriad Genetics Study Published In JCO Precision Oncology Shows Co’s Prolaris Test Can Predict Benefit Of Hormone Therapy Treatment In Men With Localized Prostate Cancer
Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1SALT LAKE CITY, May 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN),
CareDx Presents Findings from The SHORE Study, HeartCare Outperforms dd-cfDNA Alone In Identifying Rejection And Patients Experienced Fewer Biopsies
HeartCare Results Effectively Stratified Patients at Highest Risk for Acute Cellular RejectionCardiologists Performed the Fewest Biopsies After Dual Negative HeartCare Results Compared to Single or Dual Positive
Evoke Pharma Presents Additional GIMOTI Healthcare Utilization Data Focused On Gastroparesis Care Insights In Women At DDW 2024 Conference
Evoke Pharma, Inc.(NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that
Inventiva Receives Recommendation From The 4th Scheduled Data Monitoring Committee Meeting Of The NATiV3 Phase III Clinical Trial With Lanifibranor In Patients With MASH/NASH
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on the unblinded review
If You Made $70,000 When Trump Was Elected, You’d Need $90,000 Today To Keep Up
April inflation reading brings hope for soft landing scenario in US economy; S&P 500, ETFs pricing in Fed rate cuts; purchasing power down since 2017.
Attention Biotech Investors – Stocks To Watch
RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences, and Corbus Pharmaceuticals with key 2024 data readouts and trials.
Don’t Train AI On Our Content And Artists, Sony Warns AI Companies
Sony Music Group, one of the world's largest record labels, has issued a stark warning to AI companies and music streaming services. Sony prohibits any text or data mining, web scraping, or similar uses of its content for AI training or development. Representing artists like Lil Nas X and Celine Dion, Sony aims to protect intellectual property and ensure rightful compensation, urging over 700 companies to refrain from unauthorized use.